Wednesday, 13 December 2017

Questions for Chris Froome after abnormal urine test



Britain's most successful road cyclist Chris Froome is facing questions after a urine test revealed abnormal levels of an asthma drug.
 
The four-time Tour de France winner provided a sample during the 2017 Vuelta race with a concentration of Salbutamol that was double the threshold of the World Anti-Doping Agency (WADA).
 
 
Froome, who has not been provisionally suspended, vowed to cooperate with cycling's world governing body, the UCI.


"The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires," Froome said in a statement.


"It is well known that I have asthma and I know exactly what the rules are.


"I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader's jersey.


"My asthma got worse at the Vuelta so I followed the team doctor's advice to increase my Salbutamol dosage.


"As always, I took the greatest care to ensure that I did not use more than the permissible dose."


Froome, 32, had followed up his fourth Tour de France title in June by winning the Vuelta in Spain in September.
 
 
The urine test, conducted on 7 September, revealed a concentration of Salbutamol of 2,000 nanograms - twice the WADA threshold of 1,000.


Italian cyclist Alessandro Petacchi was handed a 12-month ban in 2007 for excessive use of Salbutamol during the Giro d'Italia and stripped of his five stage wins.




SKY         News.